... or advertisements. The first of these trials involved 609 haemodialysis patients with chronic kidney disease and anaemia (Hb <9 g/dl) randomised to receive IV epoetin alfa or IV epoetin zeta between 1 and 3 times a week for 24 weeks (covering the ‘correction phase' of anaemia treatment). In this randomised...

... of long-acting agents such as darbepoetin alfa has highlighted the shortcomings of this approach. To this point, we compared the in vivo activity of Epoetin alfa and darbepoetin alfa per microgram of protein core. Using the established mass-to-unit conversion for Epoetin alfa (1 µg ≅ 200 U), we...

...F. Mercuriali; G. Inghilleri; E. Biffi; M.T. Colotti; A. Vinci; G. Oriani We investigated the safety and efficacy of preoperative epoetin alfa used in conjunction with preoperative autologous blood donation (PAD) in 40 anemic orthopedic surgical patients undergoing hip replacement surgery...